Accolade shares are trading lower after the company reported Q1 financial results and issued worse-than-expected Q2 and FY25 revenue guidance. Also, Needham maintained a Buy rating on the stock but lowered its price target from $13 to $8.
Portfolio Pulse from Benzinga Newsdesk
Accolade shares are trading lower after the company reported Q1 financial results and issued worse-than-expected Q2 and FY25 revenue guidance. Needham maintained a Buy rating on the stock but lowered its price target from $13 to $8.
June 28, 2024 | 11:38 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Accolade shares are trading lower due to disappointing Q1 financial results and worse-than-expected revenue guidance for Q2 and FY25. Needham maintained a Buy rating but lowered its price target from $13 to $8.
The company's disappointing Q1 results and lower-than-expected revenue guidance for Q2 and FY25 are likely to negatively impact investor sentiment. Additionally, the reduction in the price target by Needham, despite maintaining a Buy rating, further underscores the negative outlook in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100